Previous close | 55.03 |
Open | 54.87 |
Bid | 54.99 x 1100 |
Ask | 54.93 x 800 |
Day's range | 54.52 - 55.05 |
52-week range | 44.35 - 56.22 |
Volume | |
Avg. volume | 7,936,195 |
Market cap | 80.501B |
Beta (5Y monthly) | 0.78 |
PE ratio (TTM) | 67.01 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Investors are optimistic about Boston Scientific (BSX) on strong worldwide demand for its GI and pulmonary treatment options and traction in Europe for its next-generation WATCHMAN FLX.
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Boston Scientific's (BSX) Endoscopy business within MedSurg benefits from strong worldwide demand for its broad range of GI and pulmonary treatment options.